Delcath Systems Inc.
Clinical trials sponsored by Delcath Systems Inc., explained in plain language.
-
New trial aims High-Dose chemo directly at liver tumors in breast cancer patients
Disease control Recruiting nowThis phase 2 trial tests whether delivering high-dose chemotherapy directly to the liver (using a special system) followed by standard cancer drugs works better than standard drugs alone for people with breast cancer that has spread mainly to the liver. About 90 participants will…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo targets liver tumors in hard-to-treat colorectal cancer
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer pills and an injection, works better than the standard treatment alone. It is for people whose colorectal cancer has spread mostly to the liver and is no longer responding to …
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC